Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Using single-cell sequencing, researchers found distinct immune profiles in different CNS tumors, highlighting its potential as a prognostic tool.

Beren Therapeutics P.B.C.®, the parent company of Mandos LLC® and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced that data for adrabetadex, an ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Rolvedon Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

Cyber risk management supports resilience by enabling timely, informed decisions that reduce disruption and align with enterprise performance goals. Integrating cyber into ERM frameworks ensures risks ...

With business context and group-level investigation capabilities through Cye AI, the platform enables organizations to standardize exposure measurement and strengthen enterprise-wide governance with ...

As of Friday, March 13, Replimune Group, Inc.’s REPL share price has dipped by 7.58%, which has investors questioning if this is right time to buy.

Scientists have uncovered a surprising new role for little-known brain cells called tanycytes that may influence the development of Alzheimer’s disease. These specialized cells appear to help remove ...